Today we’re diving into the world of corticosteroids and hormonal therapies — essential APIs that treat everything from asthma and autoimmune diseases to diabetes and endocrine disorders. These molecules may be decades old, but their manufacturing remains highly complex and critical to patients worldwide.

Our guest is Olivier Roux, a Senior Director at Curia. He shares how Curia partners with both startups and big pharma to simplify steroid API challenges, solve supply issues, and prepare for next-generation innovations. If you want to understand what it really takes to bring these life-changing therapies to patients, stay tuned — this conversation is packed with insights you won’t want to miss.

• 01:39 Meet Olivier Roux
• 02:20 What corticosteroids and hormonal therapies are
• 04:40 Evolution of steroidal hormonal therapies
• 05:50 Common uses of corticosteroids today
• 07:40 Key drivers of market growth
• 10:06 Curia’s agile outsourcing solutions for steroids
• 16:05 Importance of particle size control for steroids
• 17:18 Aseptic processing and high potency handling

This episode was produced with the support of Curia. Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! 

Stay updated by subscribing to our newsletter

To dive deeper into the topic: 

• Eight rare autoimmune diseases biotechs are fighting to treat
• A clearer path to relief: sinusitis treatments on the way
• Asthma study suggests lung scarring may be reversible